568 related articles for article (PubMed ID: 26202247)
1. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
2. Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
Mayer-Sonnenfeld T; Avrahami D; Friedman-Levi Y; Gabizon R
Cell Mol Neurobiol; 2008 Nov; 28(7):1005-15. PubMed ID: 18350378
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates.
Ellett LJ; Coleman BM; Shambrook MC; Johanssen VA; Collins SJ; Masters CL; Hill AF; Lawson VA
Glycobiology; 2015 Jul; 25(7):745-55. PubMed ID: 25701659
[TBL] [Abstract][Full Text] [Related]
4. Copaxone interferes with the PrP Sc-GAG interaction.
Engelstein R; Ovadia H; Gabizon R
Eur J Neurol; 2007 Aug; 14(8):877-84. PubMed ID: 17662008
[TBL] [Abstract][Full Text] [Related]
5. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
7. Variation in Chst8 gene expression level affects PrPC to PrPSc conversion efficiency in prion-infected Mov cells.
Martin R; Chantepie S; Chapuis J; Le-Duc A; Maftah A; Papy-Garcia D; Laude H; Petit JM; Gallet PF
Biochem Biophys Res Commun; 2011 Oct; 414(3):587-91. PubMed ID: 21982770
[TBL] [Abstract][Full Text] [Related]
8. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
Shoup D; Priola SA
Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
[TBL] [Abstract][Full Text] [Related]
9. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression.
Hijazi N; Kariv-Inbal Z; Gasset M; Gabizon R
J Biol Chem; 2005 Apr; 280(17):17057-61. PubMed ID: 15668233
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate is a cellular receptor for purified infectious prions.
Horonchik L; Tzaban S; Ben-Zaken O; Yedidia Y; Rouvinski A; Papy-Garcia D; Barritault D; Vlodavsky I; Taraboulos A
J Biol Chem; 2005 Apr; 280(17):17062-7. PubMed ID: 15668247
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PrPSc formation by synthetic O-sulfated glycopyranosides and their polymers.
Yamaguchi S; Nishida Y; Sasaki K; Kambara M; Kim CL; Ishiguro N; Nagatsuka T; Uzawa H; Horiuchi M
Biochem Biophys Res Commun; 2006 Oct; 349(2):485-91. PubMed ID: 16949037
[TBL] [Abstract][Full Text] [Related]
12. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
13. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
Crowell J; Hughson A; Caughey B; Bessen RA
J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
[TBL] [Abstract][Full Text] [Related]
14. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
15. Dextran sulphate inhibits an association of prions with plasma membrane at the early phase of infection.
Fuse T; Nakagaki T; Homma T; Tange H; Yamaguchi N; Atarashi R; Ishibashi D; Nishida N
Neurosci Res; 2021 Oct; 171():34-40. PubMed ID: 33476681
[TBL] [Abstract][Full Text] [Related]
16. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
[TBL] [Abstract][Full Text] [Related]
17. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
[TBL] [Abstract][Full Text] [Related]
19. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
[TBL] [Abstract][Full Text] [Related]
20. Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.
Iwahashi N; Ikezaki M; Nishikawa T; Namba N; Ohgita T; Saito H; Ihara Y; Shimanouchi T; Ino K; Uchimura K; Nishitsuji K
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33225-33234. PubMed ID: 33318190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
